Redhill Biopharma
RDHL
S$1.91
Share price
-9.20%
Change (1 day)
-85.55%
Change (1 year)
Categories
Market capitalization of Redhill Biopharma (RDHL)
Market cap: S$4.37 Million
As of July 2025 Redhill Biopharma has a market cap of S$4.37 Million. This makes Redhill Biopharma the world's 10436th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Redhill Biopharma from 2013 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$4.37 M | -63.63% |
| 2024 | S$12.02 M | -68.3% |
| 2023 | S$37.93 M | 121.15% |
| 2022 | S$17.15 M | -90.61% |
| 2021 | S$0.18 B | -54.64% |
| 2020 | S$0.40 B | 39.6% |
| 2019 | S$0.28 B | 34.19% |
| 2018 | S$0.21 B | 47.08% |
| 2017 | S$0.14 B | -43.37% |
| 2016 | S$0.25 B | 11.51% |
| 2015 | S$0.23 B | 49.61% |
| 2014 | S$0.15 B | 60.78% |
| 2013 | S$96.27 M |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Redhill Biopharma was reported to be:
S$4.36 Million
S$4.37 Million
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | S$156.36 B | 3,574,927.99% | 🇫🇷 France |
 Merck MRK | S$267.14 B | 6,107,645.41% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$98.34 B | 2,248,410.18% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | S$2.07 B | 47,440.81% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | S$24.74 B | 565,743.68% | 🇮🇱 Israel |